Small-Cap Medicine Stocks
Jun 14th, 2007 | By Penny Sleuth Contributor | Category: Investing Strategies
Some form of cancer will strike 42% of the population. And with the effectiveness of current treatments, half of those will die from it.
Those were the words of Genentech’s CEO, Dr. Arthur Levinson, when interviewed recently by The Wall Street Journal.
Levinson says that money spent on the battle against cancer ...read more
